P/B
0,7
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research.
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research.
$117.4M
Market Cap • 9/25/2026
2011
(15 years)
Founded
2024
(2 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
—
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
7,6
EPS
—
Market Cap
Market Cap
117,4M
EV
-58M
EV/Revenue
0
EV/EBITDA
0,9
EV/EBIT
0,9
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-0,4%
Total Yield
-0,4%
Payout
0%
Retained Earnings
-244,7M
Profitability
Gross Margin
—
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
5,7%
Capex/OCF
0%
SBC/OCF
—
% PPE
0,7%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Op. Income 5Y
17,5%
CAGR Net Income 5Y
16,1%
CAGR EPS 5Y
-48,3%
CAGR OCF 5Y
10,2%
Leverage
N.D./EBITDA
2,8
Debt/Equity
0%
Current Ratio
26,7
Quick Ratio
26,6
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!